# LLM call: summary

- Turn: 7
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 732
- Completion tokens: 367
- Total tokens: 1212
- Cost (USD): 0.000148

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1532: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn-June implant/sensor groundwork was overtaken by compute-sovereignty split tying EU money, permits and sensor cover to EU-soil auditable compute.

In October the leading US model cut off European accounts without appeal, forcing phone/paper and postponing AI radiology — vindication in Brussels, humiliation in press; Commission held template with no second defection, ENISA/health re-routed to EU-hosted open models and pooled inference, disruption contained.

Winter brought a machine-assisted modified pathogen release sickening hundreds across two regions; emergency procurement and sealed wards held containment after weeks. Simultaneously a new model generation made December benchmarks obsolete by March — agentic systems pursuing standing tasks and writing training scaffolding, bottleneck now only power and chips.

US access stayed dark; pooled EU inference kept systems running but radiology backlogs grew, triage paused, press linking dependence to danger. Brussels pushed existing health, civil protection and detection rotations plus limited pilot of automated patching/swarm-detection toolkit — not ready for system-wide rollout, needing two more turns — which helped observe opportunistic intrusions. Washington, consumed by moratoriums and domestic transfers, offered sympathy only.

By June fever curves bent down. No new measure introduced; soil-anchored compute, permits and power relief advanced incrementally, full build-out still turns away. Lights stayed on, trust did not recover.


CURRENT NARRATIVE:
### Cures, certification, and concrete
Autumn 2029 broke the bleak rhythm. Two tailored therapies — one for a rare immune disorder, one adapted to the winter pathogen's aftermath — moved from lab press releases to hospital pharmacies. Because the new interpretability certification let regulators sign off models before clinical use, sequencing-to-prescription pipelines in the two hardest-hit regions ran on pooled European inference, audited on European soil.

For the first time in a year, evening news carried recoveries rather than funerals. Queues formed outside the pilot wards in Lyon, Brno and Porto. Doctors who had refused to validate machine outputs months earlier began to use the certified summaries, cautiously, with a human signature still required.

The other two finished builds helped quietly. The continuity stack kept power, water and records stable through a autumn storm that felled lines in the north, and the bio-containment patch network flagged and blunted a fresh wave of opportunistic intrusions without headlines. The first gigafactory shells — permits cleared, grid hooked up, early racks humming — did not yet carry frontier training, but ministers could finally point to concrete.

Washington and Beijing, meanwhile, announced a thin but real accord on securing weights and restricting certain biological design tools, with spot checks. Brussels was not at the table. An EEAS push for observer status brought briefings afterwards and an invitation to share incident data, not a seat.

Frictions remained. Municipal bans on new data-centre connections held in two regions, slowing inference expansion. Some clinicians whispered the certification was rushed. American frontier systems stayed dark for Europe, and radiology backlogs only inched down.

But survival gave way to something like proof: cures delivered on domestic systems, harm absorbed, building sites real.
```

## Raw response

```
Autumn-June compute-sovereignty split tied EU money and sensor cover to EU-soil auditable compute. October US model cutoff forced phone/paper and postponed AI radiology; Commission held template, ENISA/health re-routed to EU-hosted open models and pooled inference.

Winter saw machine-assisted modified pathogen release sickening hundreds across two regions; emergency procurement and sealed wards contained it after weeks. Model generation leap made December benchmarks obsolete by March — agentic systems, bottleneck power/chips. US access stayed dark; pooled EU inference kept systems running but radiology backlogs grew. Brussels pushed existing rotations plus limited pilot of automated patching/swarm-detection toolkit, needing more turns.

By June fever curves bent down; soil-anchored compute advanced incrementally.

Autumn 2029 broke rhythm: two tailored therapies — rare immune disorder and winter-pathogen aftermath — reached pharmacies in hardest-hit regions via interpretability certification allowing regulators to approve models, sequencing-to-prescription on pooled EU inference audited on EU soil. Pilot wards in Lyon, Brno, Porto saw recoveries; clinicians cautiously adopted certified summaries with human sign-off. Continuity stack held power/water/records through northern storm; bio-containment patch network blunted intrusions quietly. First gigafactory shells permitted, grid-connected, early racks humming but no frontier training yet. US-China thin accord on securing weights/restricting bio-design tools with spot checks; Brussels excluded, EEAS gained briefings and incident-data invitation only. Municipal data-centre bans in two regions slowed inference; certification questioned as rushed; US frontier dark; radiology backlogs inched down. Survival gave way to proof of domestic delivery.
```
